Despite resilient demand, healthcare has taken a hit along with the rest of the market. This Big Pharma could boost profits ...

Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Jefferies analyst Michael Yee maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $350.00. The company’s ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen (AMGN – Research Report) and Align Tech (ALGN – ...

Shares of Amgen Inc. AMGN rose 1.62% to $285.98 Friday, on what proved to be an all-around great trading session for the ...

According to MarketBeat, Amgen currently has a consensus rating of “Moderate Buy” and a consensus target price of $315.22. Shares of AMGN stock opened at $285.98 on Wednesday. The stock’s 50 ...

Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. Amgen is expected to post earnings of $4.18 per ...

Amgen may be the more expensive stock, but several things suggest that it deserves its valuation premium and that its stock price can keep climbing. Amgen is generating stronger growth.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...